Clinical trial
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
NCT00009815 · University of Pittsburgh, Other · Withdrawn
Key facts
| NCT number | NCT00009815 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors |
| Official title | Phase I Study Of Oral Etoposide In Combination With ORZEL (UFT + Leucovorin) For Advanced Non-Hematological Malignancies |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | etoposide, leucovorin calcium, tegafur-uracil |
| Enrollment | 0 |
| Start date | Dec 1, 1999 |
| First posted | Apr 20, 2004 |
| Last update posted | Dec 19, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: